I am a board certified psychiatrist and neuropsychiatrist with research work that has been translational in nature and focused on elucidating the underlying pathology of brain conditions such as Autism Spectrum Disorder, substance abuse and neuropsychiatric disorders (e.g., Parkinson's disease) with an aim to find effective clinical treatments guided by molecular neuroimaging. Studies have included using in vivo PET imaging to investigate the role of neuroreceptors such as dopamine D3, serotonin 1B and 6, MGlur5 and kappa opioid systems, neuroinflammation, and most recently, synaptic density (SV2A) in clinical and nonclinical populations. Ongoing interests include imaging neuropsychiatric and addictive disorders and the demographic, social and environmental factors influencing our brain.
|NARSAD Young Investigator Award||Brain & Behavior Research Foundation||2018|
|Michael Kuhar Travel Award||International Drug and Alcohol Research Society||2011|
|NIDA-ISAM Travel Fellowship||NIDA-ISAM||2011|
|NARSAD Young Investigator Award||Brain & Behavior Research Foundation||2010|